second
Swati Mylavarapu, founder of Incite.org and an activist investor, believes the tech industry needs to acknowledge and address its societal impact. Through her investments, such as the $2 million contributed …
Tech Must Embrace Its Societal Impact: An Insightful Conversation with Swati Mylavarapu Read More
Amidst the ongoing trade tensions, Dan Ives from Wedbush Securities foresees an impending crisis for the US tech sector due to President Trump’s newly imposed tariffs. Specifically targeting companies that …
US Tech Sector Risks Economic Collapse Due to Trump’s Tariffs Read More
As we plunge deeper into 2025, the wellness landscape emerges anew, reshaping how we approach health. Last year’s trends like run clubs and biohacking lay a sturdy foundation, but this …
The Transformative Wellness Trends Shaping Our Health in 2025 Read More
A sweeping economic upheaval is upon Canada and Mexico as President Donald Trump’s monumental trade tariffs herald a downturn that hasn’t been witnessed for close to a century. The imposing …
Economic Quake: Canada and Mexico Buckle Under U.S. Tariffs Read More
Foxo Health emerges as a beacon of hope in the realm of preventive healthcare, offering a sophisticated personal healthcare assistant that tailors insights to the unique biological makeup of its …
Foxo Health: Revolutionizing Personal Healthcare with AI Insights Read More
In the dynamic realm of fitness, 2024 acts as a catalyst for transformation, ushering in a fresh wave of tailored experiences that cater to the evolving desires of health-conscious individuals. …
Fitness in Flux: Navigating Change and Fostering Wellness in 2025 Read More
Amid increasing tensions as Trump takes a hardline stance against China, U.S. companies are bracing for potential repercussions including retaliatory tariffs and a cooling business climate. The looming challenges reflect …
U.S. Companies Brace for Retaliatory Storm as Trump Targets China Read More
Vaccine maker stocks fell sharply after Donald Trump nominated Robert F. Kennedy Jr., a vaccine skeptic, to lead HHS. Stocks of major companies such as Moderna, Novavax, and Pfizer witnessed …
Trump’s HHS Pick Triggers Stock Plunge for Vaccine Makers Read More